Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
Public ClinicalTrials.gov record NCT00230789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Multiphase, Single Arm, Open Label Study To Evaluate The Effects Of Tolterodine ER In Conjunction With Behavioral Intervention On Subject Satisfaction And Over- Active Bladder Symptoms (Urgency Urinary Incontinence (UUI), Urgency, Frequency) In Overactive Bladder Subjects Who Were Dissatisfied With Their Most Recent Antimuscarinic OAB Medication Therapy.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effect of tolterodine ER in conjunction with behavioral intervention on subject satisfaction in OAB subjects who were dissatisfied with their most recent antimuscarinic OAB medication therapy.
Study identification
- NCT ID
- NCT00230789
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 417 participants
Conditions and interventions
Conditions
Interventions
- Tolterodine ER 4 mg QD Drug
- OAB Patient Behavioral Training Material Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2005 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Jan 27, 2021
2005 – 2006
United States locations
- U.S. sites
- 51
- U.S. states
- 22
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Sun Lakes | Arizona | — | — |
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Beverly Hills | California | — | — |
| Pfizer Investigational Site | Buena Park | California | — | — |
| Pfizer Investigational Site | Mission Viejo | California | — | — |
| Pfizer Investigational Site | Modesto | California | — | — |
| Pfizer Investigational Site | Oceanside | California | — | — |
| Pfizer Investigational Site | Paramount | California | — | — |
| Pfizer Investigational Site | Sacramento | California | — | — |
| Pfizer Investigational Site | Torrance | California | — | — |
| Pfizer Investigational Site | Tustin | California | — | — |
| Pfizer Investigational Site | Colorado Springs | Colorado | — | — |
| Pfizer Investigational Site | Wheat Ridge | Colorado | — | — |
| Pfizer Investigational Site | Hallandale | Florida | — | — |
| Pfizer Investigational Site | Orlando | Florida | — | — |
| Pfizer Investigational Site | Wellington | Florida | — | — |
| Pfizer Investigational Site | Woodstock | Georgia | — | — |
| Pfizer Investigational Site | Libertyville | Illinois | — | — |
| Pfizer Investigational Site | Mattoon | Illinois | — | — |
| Pfizer Investigational Site | Newton | Kansas | — | — |
| Pfizer Investigational Site | Milford | Massachusetts | — | — |
| Pfizer Investigational Site | Manchester | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Westhampton | New Jersey | — | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Endwell | New York | — | — |
| Pfizer Investigational Site | Garden City | New York | — | — |
| Pfizer Investigational Site | Poughkeepsie | New York | — | — |
| Pfizer Investigational Site | The Bronx | New York | — | — |
| Pfizer Investigational Site | Greensboro | North Carolina | — | — |
| Pfizer Investigational Site | Hickory | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Canton | Ohio | — | — |
| Pfizer Investigational Site | Zanesville | Ohio | — | — |
| Pfizer Investigational Site | Norman | Oklahoma | — | — |
| Pfizer Investigational Site | Abington | Pennsylvania | — | — |
| Pfizer Investigational Site | Bala-Cynwyd | Pennsylvania | — | — |
| Pfizer Investigational Site | Camp Hill | Pennsylvania | — | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | — | — |
| Pfizer Investigational Site | Williamsport | Pennsylvania | — | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | — | — |
| Pfizer Investigational Site | Simpsonville | South Carolina | — | — |
| Pfizer Investigational Site | Bartlett | Tennessee | — | — |
| Pfizer Investigational Site | Johnson City | Tennessee | — | — |
| Pfizer Investigational Site | New Tazewell | Tennessee | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | Provo | Utah | — | — |
| Pfizer Investigational Site | Mountlake Terrace | Washington | — | — |
| Pfizer Investigational Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00230789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00230789 live on ClinicalTrials.gov.